HARBOUR INVESTMENTS, INC. - PHASEBIO PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

PHASEBIO PHARMACEUTICALS INC's ticker is PHAS and the CUSIP is 717224109. A total of 50 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
HARBOUR INVESTMENTS, INC. ownership history of PHASEBIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$2,0000.0%3,6000.0%0.00%–
Q2 2022$2,000–3,600–0.00%–
 Download
Other shareholders

There were no reported owners of PHASEBIO PHARMACEUTICALS INC in Q2 2022.

NameSharesValueWeighting ↓
View complete list of PHASEBIO PHARMACEUTICALS INC shareholders